BLT benitec biopharma limited

xmas 2015, page-17

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    Bluebird Bio has one program (for ALD) which as has just passed the Pl/ll clinical trial stage and their MC is ~$A700M.

    Xmas 2015 would be the conclusion of our Pl/ll trial for HCV so maybe Bluebird is a guide to where we could be. (I know that HCV market is much larger than that of ALD but what matters as far as our MC is concerned is the market share that investors/big pharma think TT-034 will get.)

    Gradalis could go public before then and I wonder what their IPO would be worth?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.